Skip to main content

Table 6 Medications used in hospitalised patients with COVID-19

From: Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates

Medications

N (%)

HCQ

5945 (63.31%)

Favipiravir

5057 (53.86%)

Enoxaparin

4359 (46.42)

Camostat

1094 (11.65%)

Lopinavir/ritonavir

849 (9.04%)

Azithromycin

595 (6.34%

Chloroquine

260 (2.77%)

Tocilizumab

23 (2.5%)

Steroidsa

188 (2%)

Doxycycline

104 (1.1%)

Heparin

102 (1%)

  1. aSteroids: dexamethasone, methylprednisolone Na succinate and prednisolone